CD8A and breast cancer: In BC cells, hypoxia induces the expression of BIRC2, which counters the capability of CXCL9 to recruit CD8+ T cells and NK cells to the tumor, and hence increases tumor growth and resistance to anti-PD-1 therapy [116].